GeneDx (WGS) had the highest return between January 1, 2024 and May 31, 2024 by a mid-cap US stock, returning 626.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
GeneDx (WGS) | 1/1/2024 - 5/31/2024 | 626.3% |
Dave (DAVE) | 1/1/2024 - 5/31/2024 | 452.88% |
Sezzle (SEZL) | 1/1/2024 - 5/31/2024 | 281.81% |
Mesoblast (MESO) | 1/1/2024 - 5/31/2024 | 244.44% |
Viking Therapeutics (VKTX) | 1/1/2024 - 5/31/2024 | 236% |
Trump Media & Technology (DJT) | 1/1/2024 - 5/31/2024 | 178.29% |
Nuscale Power (SMR) | 1/1/2024 - 5/31/2024 | 169.44% |
Arcutis Biotherapeutics (ARQT) | 1/1/2024 - 5/31/2024 | 163.72% |
SharonAI Holdings, Inc Class A Common Stock (SHAZ) | 1/1/2024 - 5/31/2024 | 159.09% |
Vera Therapeutics (VERA) | 1/1/2024 - 5/31/2024 | 149.93% |
Dyne Therapeutics (DYN) | 1/1/2024 - 5/31/2024 | 144.85% |
Tutor Perini (TPC) | 1/1/2024 - 5/31/2024 | 144.84% |
Banco Macro SA B ADR (BMA) | 1/1/2024 - 5/31/2024 | 140.43% |
Definium Therapeutics (DFTX) | 1/1/2024 - 5/31/2024 | 137.84% |
SoundHound AI (SOUN) | 1/1/2024 - 5/31/2024 | 137.09% |
Nektar Therapeutics (NKTR) | 1/1/2024 - 5/31/2024 | 125.14% |
Hims Hers Health (HIMS) | 1/1/2024 - 5/31/2024 | 120.68% |
CAVA (CAVA) | 1/1/2024 - 5/31/2024 | 118.12% |
Oruka Therapeutics (ORKA) | 1/1/2024 - 5/31/2024 | 117.65% |
ZIM Integrated Shipping Services (ZIM) | 1/1/2024 - 5/31/2024 | 116.73% |
Praxis Precision Medicines (PRAX) | 1/1/2024 - 5/31/2024 | 113.4% |
BBVA Banco Frances SA ADR (BBAR) | 1/1/2024 - 5/31/2024 | 112.64% |
Perpetua Resources (PPTA) | 1/1/2024 - 5/31/2024 | 112.42% |
ADMA Biologics (ADMA) | 1/1/2024 - 5/31/2024 | 112.22% |
Dianthus Therapeutics (DNTH) | 1/1/2024 - 5/31/2024 | 110.19% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.